Physician profile
Vera Hendrix
NPI 1225490931
$3,488.91
in general payments reported to CMS, 2019-2025
16 companies · $2,509 in 2025
The $2,509 reported for 2025 was more than what 84% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $22.71 · 2021: $23.72 · 2024: $633 · 2025: $2,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790 · Travel and Lodging: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,790.18 |
| Travel and Lodging | $1,351.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $1,518.66 | 2025 | |
| Dilon Technologies, INC. | $672.20 | 2024-2025 | Hemoblast Bellows |
| Vector Surgical, LLC | $322.05 | 2024-2025 | |
| Allergan, INC. | $232.38 | 2019-2021 | |
| Stryker Corporation | $194.79 | 2024-2025 | Spy-Phi System, Molli |
| Endomagnetics Ltd | $153.45 | 2024 | Magtrace, Magseed |
| Merck Sharp & Dohme LLC | $124.44 | 2025 | Keytruda, Welireg, Keytruda Qlex |
| Boston Scientific Corporation | $91.82 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $27.03 | 2024 | Enhertu |
| Regeneron Healthcare Solutions, INC. | $25.00 | 2024 | Libtayo |
| Myriad Genetic Laboratories, INC. | $23.62 | 2025 | Myrisk |
| Pfizer INC. | $22.71 | 2020 | |
| Janssen Biotech, INC. | $22.58 | 2025 | Erleada, Rybrevant |
| Hologic Sales and Service, LLC | $21.13 | 2025 | Magtrace, Trunode, Magseed |
| Veracyte, INC. | $19.34 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Deciphera Pharmaceuticals INC. | $17.71 | 2025 | Qinlock |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vera Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.